🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Altimmune, Inc.

ALT Healthcare
$2.9 $-0.03 (-1.02%)
Market Cap: $563.98 M
Gurus Holding
4
Popularity Rank
#2579
% of Shares Held
0.51%
Net Activity (Q1 2026)
+$1.91 M

Guru Ownership Trend

Guru Analysis for Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.86 M.

Top institutional holders include Steven Cohen and Jeremy Grantham.

Institutional sentiment is currently Bullish. This is evidenced by a $1.91 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 304.1%. Conversely, Jefferies Group reduced exposure by 30.3%.

Key Holders

Top 5 by Value

$2.05 M
$389,278
$338,800
$263,198

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$2.25 M
Total Buy Value
New Buys 1
Additions 1
-$335,162.56
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Altimmune, Inc. (ALT)

Major holders include Steven Cohen ($2.05 M), Jeremy Grantham ($389,278), Jefferies Group ($338,800). According to the latest reported data, 4 tracked investment managers collectively hold approximately 987,132 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.91 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ALT. The total reported sell value was $335,162.56.

Yes, 1 managers opened new positions in ALT, and 1 increased their existing holdings. The total reported buy value was $2.25 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 665,289 $2.05 M Q1 2026
0.00% Reduce -26.8% 126,389 $389,278 Q1 2026
0.00% Reduce -30.3% 110,000 $338,800 Q1 2026
0.00% Add 304.1% 85,454 $263,198 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form